Insights from the dabigatran versus warfarin trial in patients with venous thromboembolism (the RE-COVER trial).
In this clinical trial evaluation, we revisit the RE-COVER study, a large multicenter, randomized, double-blind, noninferiority trial on patients with acute venous thromboembolism treated with dabigatran versus warfarin. Study design and key results are re-evaluated in the context of previous work and future perspectives.